Immunic receives notice of allowance for united states patent protecting vidofludimus calcium's dosing regimens in multiple sclerosis
– fundamental new patent covers treatment of multiple sclerosis into 2038 and beyond – – third u.s. patent directed to use of vidofludimus calcium in multiple sclerosis – – multilayered intellectual property strategy provides protection into 2041 in the u.s. and into 2038 internationally, unless extended further – – adds on recently allowed u.s. patent protecting specific dose strength for relapsing multiple sclerosis treatment – new york , nov. 21, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that it has received a notice of allowance from the united states patent and trademark office (uspto) for patent application 17/992,162, entitled, "compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases." specifically, the resulting patent covers dosing regimens associated with lead asset, vidofludimus calcium (imu-838), and other salt forms as well as free acid forms for the treatment of multiple sclerosis (ms), including all regimens tested in the company's ms clinical program.
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission